A Study of Mirdametinib in People With Central Nervous System Tumors
Clinical trial NCT07539441 · RECRUITING
Trial details
- NCT number
- NCT07539441
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-10
- Primary completion
- 2029-10-10
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.